Side-by-side comparison of AI visibility scores, market position, and capabilities
Burbank CA YC W20 interactive science education app for ages 4-10 with 200+ lessons and 30M+ lessons completed; $1.45M seed profitable at YC application with $9/month subscription competing with Khan Academy Kids for children STEM.
Tappity is a Burbank, California-based interactive science education app for children — backed by Y Combinator (W20) with $1.45 million in total funding including a $1.3 million seed in December 2020 from 18.Ventures, AltaIR Capital, Brighter Capital, and Y Combinator — providing children ages 4-10 with an interactive educational video library of 200+ science lessons across thousands of episodes covering physics, chemistry, biology, space, and natural science topics through an engaging, age-appropriate format that combines educational content with interactive elements. Generating subscription revenue averaging approximately $9 per month per subscriber with 5,000+ paying customers and 20,000+ weekly active users who completed 30+ million lessons as of late 2020, Tappity positions as a Netflix-for-kids-science subscription that makes science education engaging without relying on passive video consumption.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.